'Visceral leishmaniasis' diaporamas de présentation

??? ???? ?????? ??????

??? ???? ?????? ??????. Visceral, Mucocutaneous and Cutaneous Leishmaniasis Leishmaniasis is a diseases of different clinical manifestations . Leishmania donovani home the liver and spleen causing (usually fatal) visceral leishmaniasis; 2. Leishmania brasiliensis

1.24k views • 87 slides

Leishmania donovani ___________________

Leishmania donovani ___________________. Charles Louis Alphonse Laveran. France Institute Pasteur Paris, France 1845 - 1922 The Nobel Prize in Physiology or Medicine 1907 "in recognition of his work on the role played by protozoa in causing diseases".

815 views • 71 slides

Leishmaniasis

Leishmaniasis. Different stages of Haemoflagellates. Leishmania life cycle. Promastigote Amasitgote Transformation. Leishmania life cycle. Amastigotes replicate in reticuloendothelial cells (mononuclear cells) including; Monocytes Macrophages in lymph nodes, spleen, and lung;

2.55k views • 69 slides

Haemoflagellates Leishmaniasis & Trypanosomiasis

Haemoflagellates Leishmaniasis & Trypanosomiasis. Different stages of Haemoflagellates. Promastigotes of Leishmania . Amastigote of Leishmania. The life cycle of Leishmania. Leishmania Parasites and Diseases. World distribution of Visceral Leishmaniasis. Sand fly.

1.25k views • 66 slides

Leishmaniasis

Leishmaniasis. Leyi Lin, MD MAJ, MC WRAIR July 2013. http://www.niaid.nih.gov/topics/leishmaniasis. History. Sir William Boog Leishman (1865-1926) Matriculated at the University of Glasgow at 14. Joined British Army Medical Corps and served in India

727 views • 55 slides

Senior Academic Half Day: Malignant Haematology

Senior Academic Half Day: Malignant Haematology. Beth Harrison Department of Haematology University Hospitals Coventry and Warwickshire NHS Trust. Normal haematopoiesis Investigations in malignant haematology Approach to a patient with pancytopenia Diagnosis and management. Case 1.

664 views • 51 slides

Leishmaniasis

Leishmaniasis. a variety of disease manifestations focal distribution throughout world, especially tropics and subtropics new world: southern Texas to northern Argentina old world: Asia, Africa, middle east, Mediterranean transmitted by sand flies new world: Lutzomyia

1.4k views • 46 slides

????????

????????. Case presentation By : Dr , H. Mozayyeni Jan 2018. CC , PI. CC : T wo huge tumoral and cauliflowerr -like lesions on Rt elbow PI:

389 views • 38 slides

Case presentation in infection disease ???? I2 ??? ??? Jan.16, 2006

Case presentation in infection disease ???? I2 ??? ??? Jan.16, 2006. Chief Compliant. Female 22-year-old American Multiple ulcerated skin lesions on her face and extremities. Present illness. According to the statement of the patient, she was relatively healthy previously.

611 views • 34 slides

Visceral Leishmaniasis and HIV Co-infection

Felipe, Josy, Leo, Michelle & Ricky (Source: BBC) ?. Visceral Leishmaniasis and HIV Co-infection. Q: Developing treatment protocol for VL/HIV co-infected patients to prevent high rates of relapse. Overview. Introduction Prevalance of Co-infection Age Distribution of Co-infection

965 views • 29 slides

Dr.Alaa jumaa

494 views • 29 slides

Kala-Azar & PKDL

MSF Experience: Leishmaniasis control in Fulbaria Upazilla of Mymensing district Date: 1 st September, 2012. Kala-Azar & PKDL. Parasitic disease (Leishmania donovani ) Transmitted by- Sand fly Host- Human (South East Asia) and many in other parts of the world Appears as

638 views • 23 slides

LEISHMANIASIS

LEISHMANIASIS. Dr.Abdul latif Mahesar Dept.of medical pharmacology King Saud university. Pharma Team. Introductions. Leishmaniasis is a parasitic disease caused by microsopcopic protozoans of genus leishmania It was identified by a British medical officer Sir William Boog Leishman .

776 views • 21 slides

LEISHMANIASIS

LEISHMANIASIS. Dr.Abdul latif Mahesar Dept.of medical pharmacology King Saud university. Pharma Team. Introductions. Leishmaniasis is a parasitic disease caused by microsopcopic protozoans of genus leishmania It was identified by a British medical officer Sir William Boog Leishman .

448 views • 21 slides

Leishmania Donovani

Leishmania Donovani. A brief overview. Prevalence. Leishmaniasis currently infects 350 million men, women, and children in 88 countries around the world and there are three kinds: Cutaneous Mucocutaneous Visceral Some estimate that 12 million people are presently infected. Prevalence.

186 views • 17 slides

Visceral Leishmaniasis: Causes, Symptoms, Daignosis, Prevention and Treatment

Visceral Leishmaniasis is a rare disease that is characterized by irregular bouts of fever, substantial weight loss, swelling of the spleen and liver, and anemia.

321 views • 9 slides

Leishmaniasis Treatment Market Upcoming Trends, Demand and Analysis Till 2026

Leishmaniasis is parasitic disease caused due to an infection with Leishmania parasites and transmitted through the bite of infected female phlebotomine sand flies.

46 views • 4 slides

Al Swieda

Distribution of malaria vectors in Syria. Al Hasakeh. Aleppo. Al Raqua. Edleb. Lattakia. Hama. Deir Al Zour. Tartous. Superpictus. Homs. Sergenti. Sacharovi. Damascus. Clavijer. Damascus Rural. Al Quneitera. Dara. Al Swieda. Turky. Iraq. Mediterranean. Lebanon. Jordan.

416 views • 3 slides

Essential Medicines and the University Challenge: Promoting Local Research for Global Impact

Patent. Patent. Molecular Target. Cost: $200 million - $1 billion. Target Validation Biochemical Assay Screening Leads. Animal Studies Drug Metabolism Safety Assessment Clinical Trials I, II and III. Time: 8 - 15 years. A. B. C. E. D. Pharmaceutical Company for Brand Name Drug.

88 views • 1 slides